Integrated Diagnostics Finds $6.1M For Lung Cancer Diagnostics

Seattle-based Indi (Integrated Diagnostics) said on Friday that it has raised $6.1M in a financing round, for its development of a molecular diagnostic blood test which helps diagnose lung cancer

The story you have requested is only available to paid members of the Northwest Innovation web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.